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Despite the increased access to antiretroviral therapy, undernutrition is associated 
with an increased risk of early mortality among HIV-infected adults living in 
resource-limited settings.  Lipid-based Nutrient Supplements (LNS) can provide 
nutritional support and can be adapted to the needs of adults infected with HIV. 
However, consumption of these products may be limited by monotony or by an 
unacceptably strong taste of highly concentrated micronutrients. This study 
investigated the acceptability of several new flavours of LNS for HIV-infected adults 
on antiretroviral therapy (ART). Forty HIV-infected adults on ART completed 
acceptability tests with one of four sets of LNS products: LNS-30 g sweet, LNS-30 g 
non-sweet, LNS-250 g sweet and LNS-250 g non-sweet. Each set was composed of 
three flavours and was tasted with and without food during a single session of sensory 
evaluation. The supplements were block-randomised and the patients were blinded to 
the type of product. LNS acceptability was assessed based on descriptive, hedonic and 
food-action rating tests using 5-point rating scales as well as preference tests.  All the 
flavours got a median rate of 3-Just about right for the intensity of sugar, salt, oil, 
thickness and 4-Good for the taste. Regarding the overall liking, the supplements were 
positively evaluated with median of 4-I like a little or 5-I like a lot. The LNS-30 g 
non-sweet formulation was significantly less appreciated when tasted without food 
compared to all the other sets of LNS (P = 0.0005). Mixing LNS with local food had 
no effect on the acceptability. In terms of consumption pattern, all the products got a 
median rate of 1-Will eat it at all opportunity or 2-Will eat it very often. Finally, in 
terms of preference there was no significant difference between the flavours. In LNS-
30 g the overall liking was positively correlated with the taste and the intensity of 
sugar but the prospective consumption factor was negatively correlated with 
thickness. In LNS-250 g, only the intensity of salty taste was correlated with the 
overall liking. As the flavours were well accepted, all of them can be used, providing 
choice and variety to HIV-infected adults consuming them for prolonged periods. 
There is no need to modify the products’ formulation. Further research on the 
acceptability of these supplements over the longer term and in settings where food 
insecurity and dietary patterns are different is warranted. 
 









Human immunodeficiency virus (HIV) infection and undernutrition are concomitant 
major public health issues in sub-Saharan Africa. According to the 2008 Demographic 
and Health survey [1], adult HIV prevalence was estimated at 5.7% in the United 
Republic of Tanzania, with prevalence over 15% in some regions. Despite increasing 
access to antiretroviral therapy (ART), a high early mortality rate has been found 
among patients in resource-limited settings and multivariate analysis showed that 
undernutrition was among the leading causes [2-3]. In addition, in both developed and 
developing countries, low body mass index (BMI) is a strong and independent 
predictor of morbidity and mortality among HIV-infected individuals regardless of 
their ART status [3-8].  
 
The World Health Organisation (WHO) recommends for HIV-infected adults an 
energy intake above the requirements of healthy and normally active HIV-uninfected 
persons of the same age and sex [9]. Supplementary feeding in wasted HIV-infected 
patients starting or on ART is therefore common, because their elevated nutritional 
needs are often challenging to meet in resource-constrained settings [10]. 
 
In developing countries, paediatric formulas of lipid-based ready-to-use foods ─ 
energy-dense spreads ─ have also been used for the treatment of malnutrition among 
wasted HIV-infected adults with some beneficial effects on weight gain [11-12]. 
However, poor acceptability of lipid-based nutrient supplements (LNS) has been 
reported among HIV-infected adults and monotony of the diet was one of the main 
limiting factors to the LNS acceptability in adults [13]. In addition, chemosensory 
changes associated with HIV infection or ART may also influence the acceptability of 
LNS [14-17]. New flavours of LNS with high organoleptic acceptability for HIV-
infected adults are therefore urgently needed. Indeed, LNS formulations more suited 
to HIV-infected adults’ taste are thought to increase their compliance to these 
supplements [13].  
 
Nutriset SAS (Malaunay, France) has developed new formulations and flavours of 
LNS targeting undernourished HIV-infected adults to be used in the Nutritional 
Support for African adults Starting Antiretroviral Therapy (NUSTART) trial (Pan 
African Clinical Trials Registry; registration # PACTR201106000300631). In 
preparation for this trial, the present sensory evaluation was conducted to assess the 
acceptability of the new LNS flavours among HIV-infected adults in Tanzania.  The 
objectives of the study were to (i) determine the acceptability levels of the different 
LNS formulations (ii) understand and describe the sensory attributes of the 
formulations and (iii) establish the mode of consumption driving the acceptability 
levels of the formulations in this population. 
 
MATERIAL AND METHODS 
 
Study area and participants 
The acceptability trial was conducted in the HIV clinic of the Nyamagana District 
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was used to recruit the participants.  Eligible participants were adults aged 18 and 
above, infected with HIV, and either already on ART or now meeting ART eligibility 
criteria according to the Tanzanian National AIDS Control Program at the time. The 
ART eligibility criteria in Tanzania are CD4 counts ≤ 200 cells/mm3 or WHO stage 
III or IV and CD4 counts ≤ 350 cells/mm3 [18]. Since these were previously untested 
products, pregnant or lactating women were excluded. For logistic reasons we also 
excluded people unable to eat or who were involved in another potentially 
confounding trial. Eligible subjects who provided written consent were invited to 
undertake a single session of sensory test.  
 
Upon recruitment, participants' weight and height were measured to the nearest 0.1 kg 
and 0.1 cm respectively. Information on sex, age, smoking, hunger and appetite, 
changes in taste, current medication, most recent CD4 count, last 24 hours morbidity, 
time of last meal and when ART was started was obtained from the participants. 
 
This study was a pilot for the NUSTART trial and was approved by the Ethical 
Committee of London School of Hygiene and Tropical Medicine, London, United 
Kingdom and the National Institute for Medical Research, Dar es Salaam, Tanzania. 
 
LNS products 
The supplements were formulated and manufactured by Nutriset SAS (Malaunay, 
France). They were packaged in 50 g sachets and specifically labelled for the study. 
Two types of LNS were developed in preparation for the NUSTART trial: LNS-30 g 
for pre-ART nutritional support and LNS-250 g for nutritional support during ART. 
LNS-30 g has a high nutrient density, except iron, with a daily dose of 30 g. LNS-250 
g has a lower nutrient density but contains iron and 250 g are to be consumed per day. 
The common ingredients of the different LNS formulations were vegetable oil, 
peanuts, maize starch and soy flour, fortified with vitamins and minerals. For each 
type of LNS, there were “sweet” formulations with three different flavours 
(Chocolate, Chocolate-Banana and Unflavoured) and “salty or non-sweet” 
formulations also with three different flavours (Tomato, Tomato-Onion and 
Unflavoured). Therefore, there were four different sets of LNS for the study (Table 1). 
 
The acceptability of all the formulations was investigated both raw and mixed with 
local foods. The sweet formulations were mixed with a local maize-based porridge 
while the non-sweet formulations were associated with stiff maize porridge “ugali” 
plus green-leafy vegetables “mchicha”. The porridge mixture was prepared by mixing 
45 g of the sweet formulation with 50 g of fresh local maize-based porridge. The same 
serving size has previously been used in sensory trial involving porridge mixed with 
LNS [18, 19]. The tested meal including the non-sweet formulation was composed of 
approximately 15 g ugali, 5 g of mchicha and 10 g of LNS for a total serving size of 
approximately 30 g which was enough for several tastings. The foods were freshly 
prepared every morning following a local recipe and carried to the study site in a 
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Sensory trial protocol 
Block randomisation was used to assign the four sets of supplements to the 
participants. The products were assigned a three-digit identification number generated 
using Excel (Microsoft, Redmond, USA) and their identity was concealed from the 
participants and the interviewer. The participants were asked to have one spoonful or 
one bite of the product for the subsequent tests, as described below. Drinking water at 
room temperature was available for each participant. 
 
Descriptive test 
Hedonic rating scales were used to assess the sensory attributes potentially associated 
with complaints and to determine if the new formulations and flavours were 
appreciated by the participants. After the first spoon or bite, the participants were 
asked to identify and list the ingredients used for the formulation of the supplements. 
They were asked to assess the intensity of sugar, salt, oil, smell, thickness using a 
Just-about-right scale (1 = Not at all enough, 5 = Too much); and how pleasant was 
the taste of the formulations using a 5-point hedonic scale (1 = Very bad, 5 = Very 
good). 
 
Hedonic test  
Participants were asked to indicate their overall liking of the product by rating how 
much they like or dislike the products using a 5-point hedonic scale (1 = Dislike a lot, 
5 = Like a lot) and then select the main attributes driving their liking or disliking of 
the products from a list presented to them. 
 
Food-Action Rating test (FACT) 
As a proxy for the acceptability of the products, participants were asked to choose 
among the following five sentences the one which best describes their willingness to 
consume the food if freely available: 
1. I extremely like this product and I would eat it at every opportunity 
2. I moderately like this product and I would eat it very often 
3. I neither like or dislike this product and I would eat it every now and then 
4. I moderately dislike this product but I would eat it occasionally 
5. I extremely dislike this product and I would never eat it 
 
Preference test 
The participants were then asked to taste the whole set of products for a second time 
and to rank the products in order of preference with the best as number 1 and the 
worst as number 3. Finally, they were given the opportunity to make additional 
comments on the products. 
 
Statistical analysis 
Data were entered into an Excel database (Microsoft, Redmond, USA) and then, 
analysed with STATA version 11.2 (StataCorp, College Station, USA). Quantitative 
data for normally distributed variables, as assessed by box plots and skewness, were 
described using mean, standard deviation (SD) and proportion; and compared using 
Fisher’s exact test. Non-normally distributed variables were described using median 
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data and analyzed using non-parametric tests: Kruskal–Wallis test, Wilcoxon signed-
rank test or Wilcoxon sum rank test to compare 2 groups and Friedman test to 
compare more than 2 groups, as appropriate [11]. P-value < 0.05 was considered 
significant for all comparisons. The answers to the open-ended questions of the 
descriptive test were coded by reported ingredients and then analysed using 
proportions. Spearman’s correlation coefficients were calculated to investigate the 




Participants and background characteristics 
Forty participants were recruited, ten for each set of LNS. One did not take part in the 
testing of LNS mixed with food because she did not like the local food used in mixing 
the LNS. Trial participants in the four LNS groups were found to be similar so 
characteristics are shown combined (Table 2). The median age of the participants was 
39 years; most of them were female and of normal BMI. The majority were on ART 
(95%) and 93% were taking cotrimoxazole, (antimicrobial for opportunistic infections 
prophylaxis). The most common reported morbidity symptoms or discomforts in the 
past 24 hours were cold (43%), fever (35%) and cough (33%). Most participants 
reported being hungry before the sensory trial. Appetite and taste changes were 
common in the studied population and none of the participants were smokers.  
 
LNS acceptability and preference according to the type of product 
All the sets of products regardless of the formulations and the flavours were positively 
evaluated. As shown in Table 3, all the investigated attributes i.e. sugar, salt, oil, 
thickness, and smell were perceived “just about right”. The taste received a median 
rate of 4-Good. All the sets received median DOL scores of either 4-I like it a little or 
5-I like it a lot and median FACT scores of 2-I would eat it very often. When 
comparing the sets of products, the set of LNS-30 g non-sweet (tomato, tomato-onion 
and unflavoured) had the lowest median DOL of 4-I like it a little compared to all the 
other sets which each had a median DOL of 5-I like it a lot (p=0.0005). Despite the 
fact that the set of LNS-30 g non-sweet was less appreciated, there was no significant 
difference in terms of FACT rating and preference compared to the other sets. 
 
Sweet formulations 
For both 30 g and 250 g sweet LNS served without food, there were no overall 
significant differences in organoleptic properties or acceptability of the different 
formulations (chocolate, chocolate-banana, unflavoured). All LNS-30 g sweet 
formulations were considered acceptable for with a median score of 3-Just about right 
for the intensity of the studied organoleptic characteristics while the taste received a 
median score of 4-Good and the median overall DOL was 5-Like a lot for each 
flavour. Regarding the prospective consumption pattern, all these flavours received a 
favourable median FACT rate of 2-I will eat it very often. Comparable results for 250 












Figure 1: Acceptability of different flavours of LNS-250 g sweet formulations 
 
Note that for the three flavours the values for the intensity of sugar, salt, oil, thickness 




The tomato, tomato-onion and unflavoured formulations of LNS-30 g were found 
acceptable with a median of 3-Just about right for the organoleptic attributes; and a 
median rate of 4-Good for the taste (Figure 2). There was no significant difference in 
terms of overall DOL    (p = 0.60), with all the flavours rated 4-I like it a little. The 
tomato flavour was ranked as the best, following by the tomato-onion and the 
unflavoured non-sweet formulation but the difference was not significant (p = 0.18). 
Similarly, the tomato, tomato-onion and unflavoured formulations of LNS-250 g were 
found acceptable in term of organoleptic attributes, FACT rate and preference and 
there was no significant different between these three products. However, the three 
flavours of LNS-250 g non-sweet formulation received a DOL rank of 5-I like it a lot 
and were significantly more appreciated than the non-sweet formulations of LNS-30 g 
(p= 0.004).    
  
Acceptability of LNS-250g sweet formulation according to flavours 










Figure 2: Acceptability of different flavours of LNS-30 g non sweet formulations 
 
Note that for the three flavours the values for the intensity of sugar, salt, oil, thickness 
and smell as well as for the taste are completely overlapped. 
 
 
Effect of the association with local food on LNS acceptability 
All the LNS associated with foods were considered acceptable by the participants. 
Indeed, all the organoleptic characteristics received a median rate of 3-Just about 
right and 4-Good for the taste. The median overall DOL and FACT rates were 
respectively 5-Like a lot and 2-Very often. When comparing these two modes of 
consumption for LNS-30 g, there was no significant difference regarding the overall 
DOL (Table 4), the FACT rate and the preference, regardless of the flavour. These 
results were similar for LNS-250 g. 
 
Organoleptic characteristics influencing LNS acceptability 
Most of the participants were familiar with some of the LNS ingredients. Indeed, in 
the sweet formulations, 65% of the participants accurately recognised groundnut and 
33% banana. In the non-sweet formulations, 99% accurately identified groundnut and 
15% tomato. Among the studied sensory attributes, the taste, followed by the smell, 
the intensity of sugar and salty taste were the most cited by the participants liking 
LNS-30 g sweet formulations (chocolate, chocolate-banana and unflavoured). 
Acceptability of LNS-30g non sweet formulation according flavours 
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Regarding LNS-30 g non-sweet formulations (tomato, tomato-onion and 
unflavoured), the taste and the intensity of the smell were the organoleptic 
characteristics most frequently cited by the participants as the main attributes 
explaining their liking. Similar results were found for LNS-250 g. No participants 
disliked the non-sweet formulations and only two expressed dislike of the sweet 
formulations, one because of the taste and the other because of the salty taste. 
 
The investigation of the organoleptic characteristics driving the overall acceptability 
of the supplements revealed that only the intensity of sugar and the taste were 
significantly and positively correlated with the overall DOL in the LNS-30 g without 
food (Table 5). The thickness was negatively correlated with the FACT rates 
(coefficient: -0.27; p = 0.034). However, none of the sensory attributes were 
significantly correlated with the preference. In LNS-250 g, only the intensity of salt 
was significantly correlated with the DOL (coefficient: 0.28; p = 0.027). The smell 
was negatively correlated with the FACT rates (coefficient: -0.27; p = 0.043). There 




The acceptability of new flavours of LNS was investigated among HIV-infected 
Tanzanian adults. All the formulations of LNS were well accepted by the studied 
population. Indeed, all the studied sensory attributes and the overall DOL were 
reported acceptable and the FACT rates predicted frequent consumption of these 
supplements. The set of LNS-30 g non-sweet was the least appreciated compared to 
the other sets which were equally appreciated (LNS-30 g sweet, LNS-250 g sweet and 
LNS-250 g non-sweet). The thickness in LNS-30 g was negatively correlated with the 
FACT rates. Thickness as a limiting factor to LNS acceptability was previously 
suggested in a study involving HIV-infected adults [13]. The association with local 
foods did not influence either positively or negatively the acceptability of these 
products. The taste, the smell, the intensity of sugar and salt were the most important 
factors contributing to the good acceptability of the products.  
 
Before starting the sensory trial, almost all the participants reported being hungry and 
hunger is known to influence food acceptability and preference. Furthermore, taste 
preference for sugar and fats may be universal and innate [19]. This might explain 
why the LNS-30 g sweet formulations were more appreciated than the non-sweet 
ones. The high acceptability of all the supplements may also be explained by people’s 
previous experience with some of the supplements’ ingredients. Indeed, it has been 
shown that a previous experience with a food can contribute to its increased 
acceptability [20]. In this study, most of the participants were familiar with the 
flavours of the supplements.  
 
The sensory trial was conducted at the HIV clinic of Nyamagana district hospital. 
Although interviews were conducted in a particular room allocated for the research 
project, the HIV clinic environment might have influenced people’s perceptions. Food 
acceptability is influenced by the context in which food is evaluated [21] and a private 
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home.  In adults, contrary to children, taste preferences and aversions are not always 
direct predictors of food consumption. Consequently, it is difficult to link adult taste 
preferences with intake measurements, whether in a laboratory setting or in real life 
[17]. Moreover, as few studies have investigated taste response, food preference and 
intake patterns in the same adult population, the link between taste and food 
consumption is often indirectly established. Therefore, the results of the descriptive 
test were combined with the FACT rating and preference tests in order to evaluate the 
acceptability of the tested products. The triangulation of all these tests provided 
coherent results. All the rating scales used in this study were standardised scales 
previously used in resource-constrained settings among children and adults for the 
evaluation of the acceptability of different types of foods [22; 24]. In the present 
study, at least 90% of the panellists in each sensory group reported liking the 
supplements. Thus, the different new flavours may help to prevent monotony when 
LNS are consumed during a longer period. Nevertheless, it is uncertain whether 
appreciation and consumption pattern change when the products are consumed for a 
longer time. More investigation is needed to study the effect of time on the 
appreciation and the consumption pattern of these new flavours of LNS among HIV-
infected adults.  
 
The main limitation of this study was that sample size was low for logistic reasons. 
Furthermore, few participants were undernourished and most of them had a relatively 
good health status as a result of their access to ART; the median time since starting 
ART was 17.5 months. Whether the same results will be obtained in wasted HIV-
infected adults is uncertain since they might suffer severe clinical conditions affecting 




The high early mortality rate among undernourished adults infected with HIV and the 
high acceptability of the tested LNS flavours point towards the need to assess the 
effectiveness of these supplements in HIV-infected adults. As the flavours were well 
accepted, all of them can be used in effectiveness trials, providing choice and variety 
to HIV-infected adults consuming them for prolonged periods. Further research on the 
acceptability of these supplements over the longer term and in settings where food 
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Table 1: Composition of the four sets of LNS used in the sensory trial 
 
SET Type of LNS Formulation Flavours 
1 LNS-30 g Sweet Chocolate 
Chocolate-Banana 
Unflavoured 
2 LNS-30 g Non-sweet Tomato 
Tomato-Onion 
Unflavoured 
3 LSN-250 g Sweet Chocolate 
Chocolate-Banana 
Unflavoured 
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Table 2: Characteristics of the participants1 
 
Characteristics Participants 
Age, Median (range), years 39 (26-70) 
Female, No (%) 30 (75%) 
BMI, Median (range), Kg/m² 21.1 (16.6-35.9) 
BMI categories [No (%), kg/m²]  
<16.9 1 (3%) 
17.0-18.4 2 (5%) 
>18.5 37 (92%) 
CD4 count, Median (range), cells/mm3 192 (14-645) 
Current medication, No (%)  
ART2 37 (93%) 
Septrin 38 (95%) 
Anti-Tuberculosis 1 (3%) 
Other medication 4 (10%) 
Morbidity/discomfort in the past 24 hours, No (%)  
Nausea 9 (23%) 
Changes in taste 9 (23%) 
Cold 17 (43%) 
Cough 13 (33%) 
Pain when swallowing 4 (10%) 
Fever 14 (35%) 
Hungry 32 (80%) 
Appetite, No (%)  
Excellent 1 (3%) 
Good 25 (62%) 
Average 7 (17%) 
Poor 6 (15%) 
Very poor 1 (3%) 
Taste, No (%)  
Very good 0 
Good 25 (62%) 
Average 8 (20%) 
Bad 5 (13%) 
Very bad 2 (5%) 
 
1Sample size was 40 except for CD4 count which was available for only 36 participants.  
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Table 3: Acceptability of the 4 sets of LNS without food 
 
Attributes 30 g sweet 
(n= 10) 
30 g non-sweet 
(n= 10) 
250 g sweet 
(n= 10) 



































































































Overall DOL3, Median (range) 5 (1-5) 4 (4-5) 5 (4-5) 5 (2-5) 0.0005 
Food-Action-Rating, Median(range) 2 (1-5) 2 (1-3) 2 (1-3) 1 (1-4) 0.62 
Preference 2 (1-3) 2 (1-3) 2 (1-3) 2 (1-3) 1.0 
 
1 Kruskal-Wallis test 
2 Percentage of products found to be acceptable: “Just about right” for the intensity of 
sugar, salt, oil, smell and the thickness; “Good” and “Very good” for the taste 
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Table 4: Influence of consuming with food on the acceptability of LNS-30 g 
 






Chocolate 5 (4-5) 5(4-5) 0.58 
Chocolate-banana 5 (1-5) 5(4-5) 0.61 
Unflavoured sweet 5 (1-5) 5(4-5) 0.56 
Tomato 4 (4-5) 4.5 (4-5) 0.18 
Tomato-Onion 4 (4-5) 4 (4-5) 0.56 
Unflavoured non-sweet 4 (4-5) 4 (4-5) 0.08 
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Table 5: Correlation between the sensory attributes and overall DOL1 of raw 




LNS-30 g DOL LNS-250 g DOL 
Correlation 
coefficient (ρ) 2 
p-value Correlation 
coefficient (ρ) 2 
p-value 
Sugar 0.35 0.006 0.07 0.60 
Salt 0.10 0.46 0.29 0.027 
Oil 0.00001 1.00 0.15 0.25 
Taste 0.29 0.025 0.23 0.08 
Thick -0.06 0.63 -0.17 0.20 
Smell -0.01 0.94 0.11 0.41 
 
1 Degree of liking 
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